Soluble CCR2 gene therapy controls joint inflammation, cartilage damage, and the progression of osteoarthritis by targeting MCP-1 in a monosodium iodoacetate (MIA)-induced OA rat model

Na, Hyun Sik; Lee, Seon-Yeong; Lee, Dong Hwan; Woo, Jin Seok; Choi, Si-Young; Cho, Keun-Hyung; Kim, Seon Ae; Go, Eun Jeong; Lee, A Ram; Choi, Jeong-Won; Kim, Seok Jung; Cho, Mi-La

doi:10.1186/s12967-022-03515-3

Journal of Translational Medicine

Article metrics
Last updated: Mon, 15 Apr 2024 12:11:35 Z

Soluble CCR2 gene therapy controls joint inflammation, cartilage damage, and the progression of osteoarthritis by targeting MCP-1 in a monosodium iodoacetate (MIA)-induced OA rat model

Access & Citations

2024

Article Accesses
3

Web of Science
3

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1479-5876

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com